V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014298 | 260009621 | 1.75 | null | Palliative (P) | 2017-11-08 | 2017-12-06 | Cisplatin + Etoposide (5 day) | Y | N | 260029064 | CISPLATIN + ETOPOSIDE |
| 260014299 | 260016982 | 1.7 | null | Curative (C) | 2017-03-26 | 2017-04-02 | Trial Unspecified | N | N | 260029065 | TRIAL |
| 260014300 | 260009626 | 1.79 | 58.8 | Curative (C) | 2016-07-13 | 2016-07-13 | TIP | 2 | N | 260029076 | TIP |
| 260014301 | 260009628 | 1.88 | null | null | 2014-12-22 | 2015-01-12 | ETOPOSIDE | 2 | N | 260029077 | ETOPOSIDE |
| 260014302 | 260009629 | 1.53 | 0 | null | 2018-06-08 | 2018-06-08 | Methotrexate intrathecal | N | N | 260029080 | METHOTREXATE INTRATHECAL |
| 260014303 | 260009632 | null | 64.8 | Palliative (P) | 2014-03-17 | 2014-03-17 | TIP | N | N | 260029091 | TIP |
| 260014304 | 260009633 | null | 57.7 | Curative (C) | 2016-05-11 | 2016-07-13 | PACIFICO TRIAL | N | N | 260029096 | PACIFICO TRIAL |
| 260014305 | 260009635 | 1.73 | 107.4 | Neo-adjuvant (N) | 2015-05-28 | 2015-06-06 | BENDAMUSTINE | N | N | 260029097 | BENDAMUSTINE |
| 260014306 | 260014585 | null | 99 | Disease modification (D) | 2017-11-10 | 2017-11-20 | Methotrexate intrathecal | 02 | N | 260029099 | METHOTREXATE INTRATHECAL |
| 260014307 | 260009637 | 1.74 | 73 | Curative (C) | 2016-06-22 | 2016-07-13 | TIP | N | N | 260029099 | TIP |
| 260014308 | 260009638 | null | null | Curative (C) | 2015-05-16 | 2015-05-18 | TIP | 02 | N | 260029102 | TIP |
| 260014309 | 260009638 | 1.94 | 89 | Curative (C) | 2013-03-31 | 2013-12-07 | Methotrexate intrathecal | N | N | 260029102 | METHOTREXATE INTRATHECAL |
| 260014310 | 260009639 | 1.64 | 0 | Curative (C) | 2016-03-16 | 2016-03-16 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 2 | N | 260029113 | CARBOPLATIN + EPIRUBICIN + ETOPOSIDE + MELPHALAN |
| 260014311 | 260009640 | null | 98.4 | null | 2015-10-20 | 2015-10-21 | IVE | 2 | null | 260029116 | PMITCEBO-R |
| 260014312 | 260009641 | 1.58 | 75.6 | Adjuvant (A) | 2013-11-05 | 2013-11-05 | Chlorambucil + Pred + Rituximab | N | null | 260029117 | GDP |
| 260014313 | 260009642 | null | 67.6 | Palliative (P) | 2014-07-10 | 2014-07-17 | FEC 100 | 02 | N | 260029119 | R CODOX M |
| 260014314 | 260009643 | null | 68.8 | Adjuvant (A) | 2015-05-15 | 2015-05-15 | FLUDARABINE + RITUXIMAB | 02 | N | 260029129 | POMB |
| 260014315 | 260014589 | null | 85.1 | Disease modification (D) | 2016-01-15 | 2016-01-17 | Dasatinib | 02 | N | 260029129 | GEMCITABINE + OXALIPLATIN |
| 260014316 | 260009644 | 1.83 | 96 | Neo-adjuvant (N) | 2017-04-20 | 2017-04-20 | CARBO + THIOTEPA + TOPOTECAN | 2 | N | 260029135 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014317 | 260009648 | 1.67 | 55.6 | Adjuvant (A) | 2018-11-11 | 2018-11-16 | IVE-R | 2 | N | 260029137 | METHOTREXATE HIGH DOSE |
| 260014318 | 260009651 | 1.58 | 79.75 | null | 2019-05-26 | 2019-05-27 | EP | 02 | null | 260029144 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014319 | 260009652 | 1.82 | 69.3 | Palliative (P) | 2015-10-11 | 2015-10-26 | Irinotecan + Temozolomide | 02 | null | 260029145 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260014320 | 260009655 | 1.7 | 68.8 | Palliative (P) | 2015-05-10 | 2015-05-10 | DA-EPOCH-R | 2 | N | 260029154 | GDP |
| 260014321 | 260009656 | 1.74 | 65.3 | Curative (C) | 2017-09-01 | 2017-09-09 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 260029157 | IVE |
| 260014322 | 260014591 | 1.63 | null | Adjuvant (A) | 2016-06-07 | 2016-06-15 | ENRICH Trial | null | null | 260029157 | ALEMTUZUMAB |
| 260014323 | 260009657 | 1.76 | 94 | Adjuvant (A) | 2017-03-31 | 2017-04-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 260029168 | ESHAP |
| 260014324 | 260009659 | 1.71 | 67.9 | Curative (C) | 2017-08-30 | 2017-08-30 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260029169 | BORTEZOMIB |
| 260014325 | 260009661 | null | 94.1 | Curative (C) | 2017-08-08 | 2017-08-10 | R-EPOCH | 02 | N | 260029169 | DHAP - R |
| 260014326 | 260018188 | 1.68 | null | Curative (C) | 2014-08-07 | 2014-08-11 | PIXANTRONE | 2 | N | 260029183 | GEMCITABINE + RITUXIMAB |
| 260014327 | 260018790 | 1.8 | 95.8 | Curative (C) | 2016-09-19 | 2016-09-23 | CHOP - 21 days | 02 | N | 260029185 | METHOTREXATE HIGH DOSE |
| 260014328 | 260014593 | 1.76 | 64.3 | Curative (C) | 2014-10-31 | 2014-11-16 | Methotrexate High Dose (3g/m2) | N | N | 260029191 | TRIFLURIDINE + TIPIRACIL |
| 260014329 | 260014593 | 1.56 | 94.3 | Curative (C) | 2014-11-19 | 2014-11-19 | CARBOPLATIN + GEMCITABINE | N | N | 260029191 | ALEMTUZUMAB + FLUDARABINE + LEAM |
| 260014330 | 260014594 | 1.83 | 96.7 | Curative (C) | 2018-01-30 | 2018-01-30 | GEMCITABINE | N | N | 260029198 | CYTARABINE HD + METHOTREXATE HD |
| 260014331 | 260014594 | 1.63 | 78 | Curative (C) | 2014-10-03 | 2014-10-04 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260029198 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260014332 | 260014595 | 1.84 | 71.4 | Palliative (P) | 2018-01-18 | 2018-01-19 | IVE | 2 | N | 260029201 | ALEMTUZUMAB |
| 260014333 | 260009667 | 1.8 | null | Curative (C) | 2016-10-11 | 2016-10-25 | Bendamustine + Obinutuzumab | 02 | N | 260029210 | CYCLOPHOSPHAMIDE |
| 260014334 | 260009668 | 1.56 | 69.7 | Curative (C) | 2016-10-12 | 2016-10-24 | Chlorambucil | N | N | 260029212 | BEAM + ALEMTUZUMAB |
| 260014335 | 260009668 | 1.9 | null | Curative (C) | 2013-06-27 | 2013-07-15 | DA-EPOCH-R | N | N | 260029212 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 260014336 | 260009669 | 1.77 | 91 | Curative (C) | 2017-09-25 | 2017-09-26 | Methotrexate High Dose (3g/m2) | N | N | 260029218 | BORTEZOMIB |
| 260014337 | 260009670 | 1.8 | 71.7 | Curative (C) | 2014-02-03 | 2014-02-06 | ECX | 02 | null | 260029219 | CHLORAMBUCIL + RITUXIMAB |
| 260014338 | 260009671 | 1.56 | 94.3 | Curative (C) | 2017-11-29 | 2017-12-02 | GEM-P | N | N | 260029219 | DHAP - R |
| 260014339 | 260009671 | 1.7 | 63.1 | Adjuvant (A) | 2016-10-18 | 2016-10-18 | DHAP - R | 02 | N | 260029219 | CYTARABINE INTRATHECAL |
| 260014340 | 260009673 | 1.78 | 79.8 | Disease modification (D) | 2014-01-11 | 2014-04-13 | CYTARABINE + METHOTREXATE + RITUXIMAB | N | N | 260029231 | LENALIDOMIDE |
| 260014341 | 260009675 | 1.72 | 76.4 | Curative (C) | 2015-11-08 | 2016-01-10 | Methotrexate High Dose (3g/m2) | N | N | 260029233 | LIPOSOMAL CYTARABINE |
| 260014342 | 260014600 | 1.58 | 89 | Curative (C) | 2015-02-17 | 2015-02-25 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 260029235 | LIPOSOMAL DOXORUBICIN |
| 260014343 | 260009676 | 1.8 | 81.8 | Curative (C) | 2017-08-08 | 2017-08-08 | Capecitabine | 02 | N | 260029236 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014344 | 260009678 | 1.7 | 99 | Palliative (P) | 2016-11-23 | 2016-11-27 | DOCETAXEL + GEMCITABINE | 2 | N | 260029241 | GEMCITABINE + OXALIPLATIN |
| 260014345 | 260009681 | 1.53 | 70.7 | Curative (C) | 2018-04-12 | 2018-04-12 | TRASTUZUMAB | N | N | 260029242 | BLEOMYCIN + VINCRISTINE |
| 260014346 | 260009682 | 1.77 | 115 | Curative (C) | 2014-05-22 | 2014-05-27 | Ipilimumab | N | null | 260029243 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014347 | 260009683 | 1.56 | 45 | Adjuvant (A) | 2018-01-28 | 2018-01-28 | CYTARABINE + METHOTREXATE | N | null | 260029245 | CYCLO + RITUXIMAB + VINCRISTINE |